State-of-the-art of regulatory dendritic cells in cancer

Pharmacology and Therapeutics

Volumn 164, Issue , 2016, Pages 97-104

  Conejo Garcia, Jose R ^a   Rutkowski, Melanie R ^b   Cubillos Ruiz, Juan R ^c  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Dendritic cell; Emergency myelopoiesis; Immunosuppression; Tumor immunology; Tumor microenvironment

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; CELL PROTEIN; PROSTAGLANDIN E2; SATB1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MATRIX ATTACHMENT REGION BINDING PROTEIN; NANOMATERIAL; SATB1 PROTEIN, HUMAN;

ADVANCED CANCER; BIOLOGICAL THERAPY; CANCER CHEMOTHERAPY; CELL CONTACT; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; ENZYME DEGRADATION; ENZYME SYNTHESIS; GENE OVEREXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY DENDRITIC CELL; REVIEW; TARGET CELL; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; ANIMAL; BIOSYNTHESIS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MACROPHAGE; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY;

ANIMALS; DENDRITIC CELLS; DINOPROSTONE; HUMANS; IMMUNE TOLERANCE; MACROPHAGES; MATRIX ATTACHMENT REGION BINDING PROTEINS; MYELOPOIESIS; NANOSTRUCTURES; NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84975775438     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.04.003     Document Type: Review

References (70)

1. Ahonen, C.L., Wasiuk, A., Fuse, S., Turk, M.J., Ernstoff, M.S., Suriawinata, A.A. Noelle, R.J., Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood 111 (2008), 3116–3125.
2. Aspord, C., Leccia, M.T., Charles, J., Plumas, J., Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL. Cancer Immunol Res 1 (2013), 402–415.
3. Bachem, A., Guttler, S., Hartung, E., Ebstein, F., Schaefer, M., Tannert, A. Kroczek, R.A., Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J Exp Med 207 (2010), 1273–1281.
4. Baird, J.R., Fox, B.A., Sanders, K.L., Lizotte, P.H., Cubillos-Ruiz, J.R., Scarlett, U.K. Bzik, D.J., Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment. Cancer Res 73 (2013), 3842–3851.
5. Broz, M.L., Binnewies, M., Boldajipour, B., Nelson, A.E., Pollack, J.L., Erle, D.J. Krummel, M.F., Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell 26 (2014), 638–652.
6. Chen, X., Iliopoulos, D., Zhang, Q., Tang, Q., Greenblatt, M.B., Hatziapostolou, M. Glimcher, L.H., XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature 508 (2014), 103–107.
7. Clement, M., Fornasa, G., Guedj, K., Ben Mkaddem, S., Gaston, A.T., Khallou-Laschet, J. Caligiuri, G., CD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells. Proc Natl Acad Sci U S A 111 (2014), E1101–E1110.
8. Conejo-Garcia, J.R., Buckanovich, R.J., Benencia, F., Courreges, M.C., Rubin, S.C., Carroll, R.G., Coukos, G., Vascular leukocytes contribute to tumor vascularization. Blood 105 (2005), 679–681.
9. Corzo, C.A., Condamine, T., Lu, L., Cotter, M.J., Youn, J.I., Cheng, P. Gabrilovich, D.I., HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 207 (2010), 2439–2453.
10. Cubillos-Ruiz, J.R., Baird, J.R., Tesone, A.J., Rutkowski, M.R., Scarlett, U.K., Camposeco-Jacobs, A.L. Conejo-Garcia, J.R., Reprogramming tumor-associated dendritic cells in vivo using microRNA mimetics triggers protective immunity against ovarian cancer. Cancer Res 72 (2012), 1683–1693.
11. Cubillos-Ruiz, J.R., Engle, X., Scarlett, U.K., Martinez, D., Barber, A., Elgueta, R. Conejo-Garcia, J.R., Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. J Clin Invest 119 (2009), 2231–2244.
12. Cubillos-Ruiz, J.R., Martinez, D., Scarlett, U.K., Rutkowski, M.R., Nesbeth, Y.C., Camposeco-Jacobs, A.L., Conejo-Garcia, J.R., CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells. Oncotarget, 1, 2010, 329-328.
13. Cubillos-Ruiz, J.R., Silberman, P.C., Rutkowski, M.R., Chopra, S., Perales-Puchalt, A., Song, M. Glimcher, L.H., ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161 (2015), 1527–1538.
14. Curiel, T.J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P. Zou, W., Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9 (2003), 562–567.
15. Dalotto-Moreno, T., Croci, D.O., Cerliani, J.P., Martinez-Allo, V.C., Dergan-Dylon, S., Mendez-Huergo, S.P. Salatino, M., Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease. Cancer Res 73 (2013), 1107–1117.
16. Dhainaut, M., Coquerelle, C., Uzureau, S., Denoeud, J., Acolty, V., Oldenhove, G. Moser, M., Thymus-derived regulatory T cells restrain pro-inflammatory Th1 responses by downregulating CD70 on dendritic cells. EMBO J 34 (2015), 1336–1348.
17. Farren, M.R., Carlson, L.M., Netherby, C.S., Lindner, I., Li, P.K., Gabrilovich, D.I. Lee, K.P., Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCbetaII abundance. Sci Signal, 7, 2014 (ra16).
18. Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., Carbone, D.P., Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92 (1998), 4150–4166.
19. Gabrilovich, D.I., Ostrand-Rosenberg, S., Bronte, V., Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12 (2012), 253–268.
20. Ghirelli, C., Reyal, F., Jeanmougin, M., Zollinger, R., Sirven, P., Michea, P. Soumelis, V., Breast cancer cell-derived GM-CSF licenses regulatory Th2 induction by plasmacytoid predendritic cells in aggressive disease subtypes. Cancer Res 75 (2015), 2775–2787.
21. Haniffa, M., Shin, A., Bigley, V., McGovern, N., Teo, P., See, P. Ginhoux, F., Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37 (2012), 60–73.
22. Herber, D.L., Cao, W., Nefedova, Y., Novitskiy, S.V., Nagaraj, S., Tyurin, V.A. Gabrilovich, D.I., Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med 16 (2010), 880–886.
23. Hetz, C., Chevet, E., Harding, H.P., Targeting the unfolded protein response in disease. Nat Rev Drug Discov 12 (2013), 703–719.
24. Hong, Y., Manoharan, I., Suryawanshi, A., Majumdar, T., Angus-Hill, M.L., Koni, P.A. Manicassamy, S., Beta-catenin promotes regulatory T-cell responses in tumors by inducing vitamin A metabolism in dendritic cells. Cancer Res 75 (2015), 656–665.
25. Huang, L., Li, L., Lemos, H., Chandler, P.R., Pacholczyk, G., Baban, B. Mellor, A.L., Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses. J Immunol 191 (2013), 3509–3513.
26. Huarte, E., Cubillos-Ruiz, J.R., Nesbeth, Y.C., Scarlett, U.K., Martinez, D.G., Buckanovich, R.J. Conejo-Garcia, J.R., Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer Res 68 (2008), 7684–7691.
27. Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E. Rabinovich, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol 10 (2009), 981–991.
28. Karyampudi, L., Lamichhane, P., Krempski, J., Kalli, K.R., Behrens, M.D., Vargas, D.M. Knutson, K.L., PD-1 blunts the function of ovarian tumor-infiltrating dendritic cells by inactivating NF-kappaB. Cancer Res 76 (2016), 239–250.
29. Klebanoff, C.A., Spencer, S.P., Torabi-Parizi, P., Grainger, J.R., Roychoudhuri, R., Ji, Y. Restifo, N.P., Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. J Exp Med 210 (2013), 1961–1976.
30. Klechevsky, E., Flamar, A.L., Cao, Y., Blanck, J.P., Liu, M., O'Bar, A. Banchereau, J., Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood 116 (2010), 1685–1697.
31. Le, D.T., Wang-Gillam, A., Picozzi, V., Greten, T.F., Crocenzi, T., Springett, G. Jaffee, E.M., Safety and survival with GVAX pancreas prime and Listeria monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. J Clin Oncol 33 (2015), 1325–1333.
32. Lee, A.H., Iwakoshi, N.N., Glimcher, L.H., XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 23 (2003), 7448–7459.
33. Liu, Q., Zhang, C., Sun, A., Zheng, Y., Wang, L., Cao, X., Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I. J Immunol 182 (2009), 6207–6216.
34. Lu, Y., Zhang, M., Wang, S., Hong, B., Wang, Z., Li, H. Yi, Q., p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression. Nat Commun, 5, 2014, 4229.
35. Ma, Y., Shurin, G.V., Gutkin, D.W., Shurin, M.R., Tumor associated regulatory dendritic cells. Semin Cancer Biol 22 (2012), 298–306.
36. Manh, T.P., Alexandre, Y., Baranek, T., Crozat, K., Dalod, M., Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation. Eur J Immunol 43 (2013), 1706–1715.
37. Merad, M., Sathe, P., Helft, J., Miller, J., Mortha, A., The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31 (2013), 563–604.
38. Meredith, M.M., Liu, K., Darrasse-Jeze, G., Kamphorst, A.O., Schreiber, H.A., Guermonprez, P. Nussenzweig, M.C., Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med 209 (2012), 1153–1165.
39. Metz, R., Smith, C., DuHadaway, J.B., Chandler, P., Baban, B., Merlo, L.M. Prendergast, G.C., IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int Immunol 26 (2014), 357–367.
40. Munn, D.H., Mellor, A.L., IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance. Trends Immunol 37 (2016), 193–207.
41. Norian, L.A., Rodriguez, P.C., O'Mara, L.A., Zabaleta, J., Ochoa, A.C., Cella, M., Allen, P.M., Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res 69 (2009), 3086–3094.
42. O'Keeffe, M., Mok, W.H., Radford, K.J., Human dendritic cell subsets and function in health and disease. Cell Mol Life Sci 72 (2015), 4309–4325.
43. Ostrand-Rosenberg, S., Sinha, P., Myeloid-derived suppressor cells: Linking inflammation and cancer. J Immunol 182 (2009), 4499–4506.
44. Pardoll, D.M., The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12 (2012), 252–264.
45. Pedroza-Gonzalez, A., Zhou, G., Vargas-Mendez, E., Boor, P.P., Mancham, S., Verhoef, C. Sprengers, D., Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors. Oncoimmunology, 4, 2015, e1008355.
46. Poltorak, M.P., Schraml, B.U., Fate mapping of dendritic cells. Front Immunol, 6, 2015, 199.
47. Raker, V.K., Domogalla, M.P., Steinbrink, K., Tolerogenic dendritic cells for regulatory T cell induction in man. Front Immunol, 6, 2015, 569.
48. Rutkowski, M.R., Stephen, T.L., Svoronos, N., Allegrezza, M.J., Tesone, A.J., Perales-Puchalt, A. Conejo-Garcia, J.R., Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. Cancer Cell 27 (2015), 27–40.
49. Said, A., Weindl, G., Regulation of dendritic cell function in inflammation. J Immunol Res, 2015, 2015, 743169.
50. Satpathy, A.T., Kc, W., Albring, J.C., Edelson, B.T., Kretzer, N.M., Bhattacharya, D. Murphy, K.M., Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J Exp Med 209 (2012), 1135–1152.
51. Scarlett, U.K., Cubillos-Ruiz, J.R., Nesbeth, Y.C., Martinez, D.G., Engle, X., Gewirtz, A.T. Conejo-Garcia, J.R., In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells. Cancer Res 69 (2009), 7329–7337.
52. Scarlett, U.K., Rutkowski, M.R., Rauwerdink, A.M., Fields, J., Escovar-Fadul, X., Baird, J. Conejo-Garcia, J.R., Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J Exp Med 209 (2012), 495–506.
53. Schraml, B.U., van Blijswijk, J., Zelenay, S., Whitney, P.G., Filby, A., Acton, S.E. Reis e Sousa, C., Genetic tracing via DNGR-1 expression history defines dendritic cells as a hematopoietic lineage. Cell 154 (2013), 843–858.
54. Segura, E., Amigorena, S., Inflammatory dendritic cells in mice and humans. Trends Immunol 34 (2013), 440–445.
55. Segura, E., Amigorena, S., Inflammatory dendritic cells. Med Sci (Paris) 30 (2014), 64–68.
56. Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., Hosmalin, A. Amigorena, S., Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38 (2013), 336–348.
57. Shurin, G.V., Ma, Y., Shurin, M.R., Immunosuppressive mechanisms of regulatory dendritic cells in cancer. Cancer Microenviron 6 (2013), 159–167.
58. Sisirak, V., Faget, J., Vey, N., Blay, J.Y., Menetrier-Caux, C., Caux, C., Bendriss-Vermare, N., Plasmacytoid dendritic cells deficient in IFNalpha production promote the amplification of FOXP3 regulatory T cells and are associated with poor prognosis in breast cancer patients. Oncoimmunology, 2, 2013, e22338.
59. Suryawanshi, A., Manicassamy, S., Tumors induce immune tolerance through activation of beta-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy. Oncoimmunology, 4, 2015, e1052932.
60. Takizawa, H., Boettcher, S., Manz, M.G., Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 119 (2012), 2991–3002.
61. Tang, C.H., Ranatunga, S., Kriss, C.L., Cubitt, C.L., Tao, J., Pinilla-Ibarz, J.A. Hu, C.C., Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival. J Clin Invest 124 (2014), 2585–2598.
62. Tesone, A.J., Rutkowski, M.R., Brencicova, E., Svoronos, N., Perales-Puchalt, A., Stephen, T.L. Conejo-Garcia, J.R., Satb1 overexpression drives tumor-promoting activities in cancer-associated dendritic cells. Cell Rep 14 (2016), 1774–1786.
63. Torres-Aguilar, H., Aguilar-Ruiz, S.R., Gonzalez-Perez, G., Munguia, R., Bajana, S., Meraz-Rios, M.A., Sanchez-Torres, C., Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol 184 (2010), 1765–1775.
64. Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Hernandez, J.D. Rabinovich, G.A., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 8 (2007), 825–834.
65. Wang, J., Lu, Z.H., Gabius, H.J., Rohowsky-Kochan, C., Ledeen, R.W., Wu, G., Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol 182 (2009), 4036–4045.
66. Wei, S., Kryczek, I., Zou, L., Daniel, B., Cheng, P., Mottram, P. Zou, W., Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 65 (2005), 5020–5026.
67. Yang, Y., Hou, J., Lin, Z., Zhuo, H., Chen, D., Zhang, X. Sun, B., Attenuated Listeria monocytogenes as a cancer vaccine vector for the delivery of CD24, a biomarker for hepatic cancer stem cells. Cell Mol Immunol 11 (2014), 184–196.
68. Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., Mori, K., XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107 (2001), 881–891.
69. Zhong, K., Song, W., Wang, Q., Wang, C., Liu, X., Chen, D. Zhang, M., Murine myeloid dendritic cells that phagocytose apoptotic T cells inhibit the immune response via NO. PLoS One, 7, 2012, e49378.
70. Zonari, E., Pucci, F., Saini, M., Mazzieri, R., Politi, L.S., Gentner, B., Naldini, L., A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. Blood 122 (2013), 243–252.